• No results found

A reappraisal of Stegastes species occurring in the South Atlantic using morphological and molecular data

N/A
N/A
Protected

Academic year: 2020

Share "A reappraisal of Stegastes species occurring in the South Atlantic using morphological and molecular data"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1 Map showing the geographic distributions of Stegastes variabilis and S. fuscus (red), S
Fig. 2 Specimens of a Stegastes variabilis Castelnau 1855, b S. fuscus Cuvier 1830, c S
Table 1 Stegastes specimens analyzed and GenBank accession numbers of mitochondrial and nuclear sequences used in phylogenetic estimates
Table 3 Frequency distribution of counts for 7 species of Stegastes from the Western Atlantic
+4

References

Related documents

Moreover, inhi- bition of STAT5 activation by treatment of the cells with the ABL1 kinase inhibitor imatinib led to downregulation of the STAT5 target genes ( Figures 2 I, 2J, and

Davis, Mary Dawson, Carol de Cardenas, Noah De Lissovoy, Stacia & Walt DeBill, Mikey DeLeon, Tavo Deleon, Erica Demme, designED Engagement, Flavio Devide, Michael DeVivo,

Problem Outline Problem Process Analysis P ro SProblempace Stakeholder Discovery Stakeholder Goal Discovery Stakeholder Value Analysis Stakeholder Prioritization Pro

Microhabitat use explained 32 to 49% of the variation in abundance among these 13 sites for 3 of the damselfish species (Stegastes planifrons, S. Only one parrotfish [Scarrls

Our studies showed that Fusarium solani was the most common of Fusarium species in the rhizosphere soils around transgenic insect-resistant cotton plants in the Mexicali

SAN FRANCISCO SKYLINE CHOCOLATE- COVERED ASSORTMENT Includes milk chocolate-covered almonds, dark chocolate-covered almonds, milk chocolate-covered raisins, and

These individuals submitted their credentials to the State Archaeologist and were found to meet or exceed the professional requirements for archaeologists as stated

Based on discussions with industry personnel, ERG concluded that virtually none of these smaller wholesalers have formal distribution contracts with drug manufacturers and thus,